Cell adhesion proteins as tumor suppressors

Journal of Urology

Volumn 167, Issue 4 I, 2002, Pages 1836-1843

  Okegawa, Takatsugu ^a   Li, Yingming ^a   Pong, Rey Chen ^a   Hsieh, Jer Tsong ^a,b  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Cell adhesion molecules; Urinary tract; Urologic neoplasms

Indexed keywords

CADHERIN; CELL ADHESION MOLECULE; CELL PROTEIN; IMMUNOGLOBULIN; INTEGRIN; INTERCELLULAR ADHESION MOLECULE 1; MEMBRANE PROTEIN; SELECTIN;

CANCER GROWTH; CANCER INHIBITION; CANCER INVASION; CANCER RECURRENCE; CELL ADHESION; CELL DIFFERENTIATION; CELL GROWTH; CELL INTERACTION; CELL MOTILITY; EXTRACELLULAR MATRIX; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNE FUNCTION TEST; INFLAMMATION; LAMINA PROPRIA; METASTASIS; MORPHOGENESIS; PEER REVIEW; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; PUBLICATION; REVIEW; SIGNAL TRANSDUCTION; TUMOR GROWTH; URINARY TRACT CANCER; WOUND HEALING;

EID: 0036129748     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0022-5347(05)65245-7     Document Type: Review

References (129)

1. Cellular adhesion molecules in urologic malignancies
2. In vitro modulation of tumor progression-associated properties of hormone refractory prostate carcinoma cell lines by cytokines
3. Levels of circulating intercellular adhesion molecule-1 in patients with metastatic cancer of the prostate and benign prostatic hyperplasia
4. Intercellular adhesion molecule-1 expression by bladder cancer cells: Functional effects
5. Defective expression of adhesion molecules on human bladder tumour and human tumour cell lines
6. Cloning and expression of a cDNA coding for a rat liver plasma membrane ecto-ATPase. The primary structure of the ecto-ATPase is similar to that of the human biliary glycoprotein I
7. Intercellular adhesion of rat hepatocytes. Identification of a cell surface glycoprotein involved in the initial adhesion process
8. Androgen regulation of cell adhesion molecule gene expression in rat prostate during organ degeneration. C-CAM belongs to a class of androgen-repressed genes associated with enriched stem/amplifying cell population after prolonged castration
9. Consistent expression of an epithelial cell adhesion molecule (C-CAM) during human prostate development and loss of expression in PROSTATE CANCER: Implication as a tumor suppressor
10. Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth: A stem cell model
11. Clinical and experimental studies of benign prostatic hyperplasia
12. Differential expression of C-CAM cell adhesion molecule in prostate carcinogenesis in a transgenic mouse model
13. Alterations in the expression of a hepatocyte cell adhesion molecule by transplantable rat hepatocellular carcinomas
14. Biliary glycoprotein, a potential human cell adhesion molecule, is down-regulated in colorectal carcinomas
15. The expression of mouse biliary glycoprotein, a carcinoembryonic antigen-related gene, is down-regulated in malignant mouse tissues
16. Tumor suppressive role of an androgen-regulated epithelial cell adhesion molecule (C-CAM) in prostate carcinoma cell revealed by sense and antisense approaches
17. Structural analysis of the C-CAM1 molecule for its tumor suppression function in human prostate cancer
18. Signal transduction by the CEACAM1: Phosphorylation of serine 503 is required for growth-inhibitory activity
19. Association of an 80 kDa protein with C-CAM1 cytoplasmic domain correlates with C-CAM1-mediated growth inhibition
20. Application of a tumor suppressor gene, C-CAM1, in androgen-independent prostate cancer therapy: A preclinical study
21. Suppression of human bladder cancer growth by increased expression of C-CAM1 gene in an orthotopic model
22. Identification of a chromosome 18q gene that is altered in colorectal cancers
23. Frazzled encodes a Drosophila member of the DCC immunoglobulin subfamily and is required for CNS and motor axon guidance
24. Phenotype of mice lacking functional deleted in colorectal cancer (DCC) gene
25. The DCC gene product in cellular differentiation and colorectal tumorigenesis
26. DCC: Linking tumor suppressor genes and altered cell surface interactions in cancer?
27. Induction of apoptosis and G2/M cell cycle arrest by DCC
28. Loss of heterozygosity on chromosome 18q is associated with muscle-invasive transitional cell carcinoma of the bladder
29. Loss of heterozygosity at the p53, RBDCC and APC tumor suppressor gene loci in human bladder cancer
30. Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5
31. HCAR and MCAR: The human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses
32. Dimeric structure of the coxsackievirus and adenovirus receptor D1 domain at 1.7 Å resolution
33. Loss of adenoviral receptor expression in human bladder cancer cells: A potential impact on the efficacy of gene therapy
34. The impact of coxsackie and adenovirus receptor on human prostate cancer gene therapy
35. The mechanism of growth inhibitory effect of Coxsackie and adenovirus receptor (CAR) on human bladder cancer: A functional analysis of CAR protein structure
36. WAF1/CIP1 mutation in superficial and invasive transitional carcinoma cell
37. Cadherin cell adhesion receptors as a morphogenetic regulator
38. Cell adhesion as tumor suppressors
39. Dissecting tumor cell invasion: Epithelial cells acquire invasive properties after the loss of uvomorulin-mediated cell-cell adhesion
40. The differential expression of N-cadherin and E-cadherin distinguishes pleural mesotheliomas from lung adenocarcinomas
41. Expression of E-cadherin and N-cadherin in surface epithelial-stromal tumors of the ovary distinguishes mucinous from serous and endometrioid tumors
42. Cell-adhesion molecule uvomorulin is localized in the intermediate junctions of adult intestinal epithelial cells
43. Cadherin expression in carcinomas: Role in the formation of cell junctions and the prevention of invasiveness
44. Spatial and temporal expression pattern of N-cadherin cell adhesion molecules correlated with morphogenetic processes of chicken embryos
45. A novel cadherin cell adhesion molecule: Its expression patterns associated with implantation and organogenesis of mouse embryos
46. Expression and role of E- and P-cadherin adhesion molecules in embryonic histogenesis. I. Lung epithelial morphogenesis
47. Expression and role of E- and P-cadherin adhesion molecules in embryonic histogenesis. II. Skin morphogenesis
48. Cadherin celladhesion molecules in human epithelial tissues and carcinomas
49. Expression and functional role of E- and P-cadherins in mouse mammary ductal morphogenesis and growth
50. Cadherin celladhesion molecules in human epithelial tissues and carcinomas
51. The cytoplasmic domain of the cell adhesion molecule uvomorulin associates with three independent proteins structurally related in different species
52. Genetic and biochemical dissection of protein linkages in the cadherincatenin complex
53. Dissecting tumor cell invasion: Epithelial cells acquire invasive properties after the loss of uvomorulin-mediated cell-cell adhesion
54. Decreased expression of E-cadherin in the progression of rat prostatic cancer
55. Three distinct commonly deleted regions of chromosome arm 16q in human primary and metastatic prostate cancers
56. Expression of E-cadherin in primary and metastatic prostate cancer
57. E-cadherin: A marker for differentiation and invasiveness in prostatic carcinoma
58. E-cadherin expression in prostatic carcinoma biopsies: Correlation with tumor grade, DNA content, pathologic stage, and clinical outcome
59. Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer
60. E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas
61. N-cadherin promotes adhesion between invasive breast cancer cells and the stroma
62. Tissue architecture: The ultimate regulator of epithelial function?
63. Expression of cadherins in benign, borderline, and malignant ovarian epithelial tumors: A clinicopathologic study of 60 cases
64. E-, N- and P-cadherin and α-, β- and γ-catenin protein expression in normal, hyperplastic and carcinomatous human prostate
65. P-Cadherin is a basal cell-specific epithelial marker that is not expressed in prostate cancer
66. Expression of P-cadherin identifies prostate-specific-antigen-negative cells in epithelial tissues of male sexual accessory organs and in prostatic carcinomas. Implications for prostate cancer biology
67. Methylation of the CD44 metastasis suppressor gene in human prostate cancer
68. The cytoplasmic domain of the cell adhesion molecule uvomorulin associates with three independent proteins structurally related in different species
69. Molecular linkage between cadherins and actin filaments in cell-cell adherens junctions
70. Reduction of E-cadherin levels and deletion of the alpha-catenin gene in human prostate cancer cells
71. Assignment of the human α-catenin gene (CTNNA1) to chromosome 5q21-q22
72. Chromosome 5 suppresses tumorigenicity of PC3 prostate cancer cells: Correlation with re-expression of alpha-catenin and restoration of E-cadherin function
73. Alterations in beta-catenin phosphorylation and plakoglobin expression in human breast cancer cells
74. Association of the APC gene product with beta-catenin
75. Association of the APC tumor suppressor protein with catenins
76. Wingless signaling: The inconvenient complexities of life
77. Nuclear localization of beta-catenin by interaction with transcription factor LEF-1
78. Functional interaction of beta-catenin with the transcription factor LEF-1
79. Tyrosine phosphorylation and cadherin/catenin function
80. E-cadherin and α-, β- and γ-catenin expression in prostate cancers: Correlation with tumour invasion
81. A lectin histochemistry comparative study in human normal prostate, benign prostatic hyperplasia, and prostatic carcinoma
82. Dissecting tumor cell invasion: Epithelial cells acquire invasive properties after the loss of uvomorulin-mediated cell-cell adhesion
83. E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells
84. The significance of E-cadherin in transitional-cell carcinoma of the human urinary bladder
85. E-cadherin expression in bladder cancer using formalin-fixed, paraffinembedded tissues: Correlation with histopathological grade, tumour stage and survival
86. Reduced expression of E-cadherin is related to invasive disease and frequent recurrence in bladder cancer
87. Prognostic value of cadherin-associated molecules (α-, β-, and γ-catenins and p120cas) in bladder tumors
88. Cell adhesion molecules in bladder cancer: Soluble serum E-cadherin correlates with predictors of recurrence
89. Soluble forms of the adhesion molecule E-cadherin in urine
90. Molecular alterations of E-cadherin gene: Possible role in human bladder carcinogenesis
91. Low E-cadherin expression in bladder cancer at the transcriptional and protein level provides prognostic information
92. Soluble E-cadherin fragments increased in circulation of cancer patients
93. Complex cadherin expression in renal cell carcinoma
94. E-cadherin expression in renal cell cancer and its significance in metastasis and survival
95. Cadherin-6, a cell adhesion molecule specifically expressed in the proximal renal tubule and renal cell carcinoma
96. Cadherins in renal cell carcinoma
97. Leukocyte integrins: Structure, function and regulation of their activity
98. Role of integrins in cancer: Survey of expression patterns
99. The impact of molecular biology on models for cell adhesion
100. Integrin recognition of different cell-binding fragments of laminin (P1, E3, E8) and evidence that alpha 6 beta 1 but not alpha 6 beta 4 functions as a major receptor for fragment E8
101. VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site
102. A synthetic peptide from fibronectin inhibits experimental metastasis of murine melanoma cells
103. A novel Arg-Gly-Asp containing peptide specific for platelet aggregation and its effect on tumor metastasis: A possible mechanism of RGD peptide-mediated inhibition of tumor metastasis
104. Signaling by integrins: Implications for tumorigenesis
105. The α6β1 and α6β4 integrins in human prostate cancer progression
106. Downregulation of the beta4 integrin subunit in prostatic carcinoma and prostatic intraepithelial neoplasia
107. Role of alphaII(b)beta3 integrin in prostate cancer metastasis
108. Bone cell matrix promotes the adhesion of human prostatic carcinoma cells via the α2β1 integrin
109. Extracellular matrix and integrin composition of the normal bladder wall
110. Loss of co-localization of alpha 6 beta 4 integrin and collagen VII in bladder cancer
111. Expression of alpha 6 beta 4 integrin provides prognostic information in bladder cancer
112. Expression of the VLA beta 1 integrin family in bladder cancer
113. Prognostic significance of microscopic vascularity for clear cell renal cell carcinoma
114. Integrins and laminins in human renal carcinoma cells and tumors grown in nude mice
115. Renal cell carcinoma: Immunohistological investigation of expression of the integrin αVβ3
116. Serum levels of endothelial and neural cell adhesion molecules in prostate cancer
117. Lack of selectindependent adhesion in prostate cancer cells expressing sialyl Le(x)
118. Metastatic potential of human uroepithelial cancer cells is not dependent on their adhesion to E-selectin
119. CD44 and its interaction with extracellular matrix
120. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells
121. Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons
122. CD44 is a metastasis suppressor gene for prostatic cancer located on human chromosome 11p13
123. Methylation of the CD44 metastasis suppressor gene in human prostate cancer
124. Expressions of E-cadherin and exon v6-containing isoforms of CD44 and their prognostic values in human transitional cell carcinoma
125. Expression of the CD44 cell adhesion molecule in urinary bladder transitional cell carcinoma
126. Progressive loss of CD44 gene expression in invasive bladder cancer
127. Correlation of very late activation integrin and CD44 expression with extrarenal invasion and metastasis of renal cell carcinomas
128. Expression of CD44 isoforms in renal cell tumors. Positive correlation to tumor differentiation
129. In vitro modulation of the invasive and metastatic potentials of human renal cell carcinoma by interleukin-2 and/or interferon-alpha gene transfer